Today: 19 May 2026
Petrobras (PBR) jumps on Q3 results, R$12.16bn dividend and faster capex — Today, 7 November 2025
12 November 2025
3 mins read

Petrobras Stock Today (12.11.2025): PBR and PETR4 Slip as Oil Softens; Braskem Deal Buzz Fades and Dividend Dates Near

Updated: November 12, 2025 — Tickers: NYSE:PBR, B3:PETR4 / PETR3

Brazil’s state‑controlled oil major Petrobras traded lower on Wednesday as crude prices softened again and investors weighed labor tensions and mixed headlines around Braskem’s ownership. In New York, PBR dipped in midday trade; in São Paulo, PETR4 also moved down alongside the Ibovespa. Meanwhile, the company’s recently approved interim shareholder remuneration and a new five‑year plan due this month remain the key near‑term catalysts.


How Petrobras stock is trading today

  • U.S. ADRs (PBR): Shares were recently quoted around $13, down roughly 3–4% on the session, with the day’s range near $12.9–$13.3 according to LSEG data via Reuters. That compares with a previous close of $13.47.
  • Brazil (PETR4): By late morning in São Paulo, PETR4 fell ~2–3% intraday (range R$32.08–R$33.26), echoing broader weakness in oil‑linked names.

Why the dip? Oil eased again on Wednesday as traders focused on oversupply signals; one widely‑followed update showed Brent sliding more than 2% intraday. That macro backdrop tends to pressure integrated producers like Petrobras.


The news driving today’s narrative

1) Braskem sale chatter meets a reality check

Overnight, Braskem said there was no “material progress” in talks regarding controlling shareholder Novonor’s stake, tamping down expectations after earlier reports suggested a deal was close with IG4 Capital. Petrobras is a significant Braskem shareholder and holds rights that make any deal strategically relevant for the oil major, so headlines here can ripple into Petrobras shares. Reuters+2Reuters+2

2) Labor tensions linger

On Monday, Petrobras’ unions approved a “state of strike” after rejecting a proposed collective bargaining agreement—allowing a stoppage at any time if talks break down. While not an immediate strike, the posture keeps operational risk on investors’ radar this week. Reuters

3) Fresh dividend details and the payout calendar

Petrobras’ board last week approved R$12.16 billion in interim remuneration—equal to R$0.94320755 per common and preferred share, to be paid in two installments on Feb. 20 and Mar. 20, 2026 (with ADR holders receiving payments starting Feb. 27 and Mar. 27). The ex‑date on B3 is Dec. 23, 2025, and the company will define whether the payment is dividend and/or interest on equity by Dec. 11.

That board action followed Q3 results showing net income of R$32.7 billion and a resumption of hefty shareholder returns, even as revenue softened slightly.

4) Strategy and capex pacing

Management has flagged faster‑than‑planned investments this year and will unveil the 2026–2030 strategic plan on Nov. 27, a key event for guidance on production, refining, and potential renewables or gas moves. Executives have said ~90% of 2026 projects are already contracted, limiting short‑term flexibility.


What it means for investors today

  • Macro beats micro (for now): With Brent back on the defensive, Petrobras—despite strong pre‑salt execution—trades like a macro proxy. If crude stabilizes, the stock’s heavy cash generation can come back into focus quickly.
  • Event risk is two‑sided: The Braskem outcome could reshape Petrobras’ exposure to chemicals (depending on any exercise of rights or eventual governance changes), while union negotiations could sway near‑term refining/production operations if talks stall.
  • Income remains a pillar: The R$0.94320755/share interim remuneration approved last week—on top of previously declared 2025 payments—underscores Petrobras’ commitment to its 45% free‑cash‑flow distribution policy when gross debt sits at or below the US$75 billion cap in its plan.

Quick refresher: Q3 scorecard in one glance

Petrobras printed R$32.7 billion in Q3 net profit and announced R$12.2 billion in distributions tied to the quarter, supported by record output from pre‑salt fields even as global oil prices weakened. The mix of resilient EBITDA and disciplined capex kept the balance sheet within the policy thresholds that allow cash returns.


Key dates & levels to watch

  • Nov. 21 & Dec. 22, 2025: Additional 2025 payments on the company’s calendar (“to pay”), per the investor relations schedule. Ex‑date on B3: Dec. 23; ADR record date: Dec. 26. Petrobras+1
  • Nov. 27, 2025:Strategic Plan 2026–2030 announcement.
  • Labor talks: Monitoring for any escalation from “state of strike” to defined actions at refineries/offshore units. Reuters
  • Oil trend: Persistent oversupply headlines keep pressure on Brent; price stabilization would be supportive for Petrobras beta.

Bottom line

Today’s move in Petrobras reflects a risk‑off oil tape more than a change in company fundamentals. The market is toggling between macro headwinds (softer crude) and company‑specific supports—notably robust cash returns, record pre‑salt volumes, and a strategy update due this month. Keep an eye on Braskem headlines and union negotiations—both are meaningful swing factors around a still‑healthy dividend story.


Disclosures & notes

This article is for information purposes only and is not investment advice. Prices and performance figures referenced above reflect intraday data from reliable sources at the time of writing. Always do your own research before investing.

Sources: LSEG/Reuters price pages; Petrobras investor relations filings; Reuters, Bloomberg and Brazilian financial media for market context and headlines.

Stock Market Today

  • 5 Key Stocks in Accident & Health Insurance Sector to Watch in 2024
    May 19, 2026, 2:58 PM EDT. The Zacks Accident and Health Insurance industry is positioned for growth amid increased underwriting exposure, with companies like Aflac, Unum Group, Trupanion, Employers Holdings, and AMERISAFE leading the charge. Despite challenges from sustained inflation and rising medical costs, the sector benefits from prudent underwriting and improved claims management. Industry pricing remains soft due to competitive pressure, yet claims frequency is improving as business activity normalizes. The global workers' compensation market is forecasted to grow strongly through 2032, driven by rising awareness and demand for coverage. However, pricing pressure is expected to persist due to economic factors and healthcare spending growth, potentially limiting revenue expansion. Technological adoption and safety improvements underpin operational stability and future prospects in this sector.

Latest articles

Marvell Stock Is Jumping Again — The AI Chip Trade Has One Week To Prove It

Marvell Stock Is Jumping Again — The AI Chip Trade Has One Week To Prove It

19 May 2026
Marvell shares climbed 6.6% to $180.04 Tuesday, outperforming a falling Nasdaq as investors positioned ahead of its May 27 earnings call. Trading volume reached 15.3 million shares, with the company’s market value near $155.5 billion. The stock’s rally followed analyst price target hikes and speculation over AI data-center demand. Marvell last reported record annual revenue and forecast further growth led by its data-center business.
Enbridge Stock Hits a 52-Week High Even as Line 5 Fight Throws Up a Fresh Risk

Enbridge Stock Hits a 52-Week High Even as Line 5 Fight Throws Up a Fresh Risk

19 May 2026
Enbridge Inc. shares hit a 52-week high of C$78.25 on Tuesday, rising 2.76% even as the S&P/TSX Composite slipped 0.1% amid inflation concerns. The move came after the company reaffirmed 2026 financial guidance and despite a partial construction pause on its Line 5 project in Wisconsin. Pembina Pipeline shares also rose, though less sharply.
Amazon shares fall as $200 billion AI question lingers

Amazon shares fall as $200 billion AI question lingers

19 May 2026
Amazon shares fell 2.3% to $258.73 Tuesday, underperforming the S&P 500 and Nasdaq as investors trimmed tech holdings ahead of Nvidia’s earnings. AWS revenue jumped 28% to $37.6 billion last quarter, but Amazon’s free cash flow dropped to $1.2 billion over the past year from $25.9 billion, reflecting heavy AI spending.
Pfizer (PFE) Stock at a Crossroads: Big Dividend, Weight-Loss Gamble & 2025 Outlook
Previous Story

Pfizer (PFE) Stock Today, November 12, 2025: Shares Nudge Higher as Jefferies Webcast Set, Metsera Deal Stays in Focus

Westpac’s $7 Billion Windfall Ignites ASX Rally Despite Mining Slump – Nov 3, 2025
Next Story

ASX Pre‑Open: Futures Point Higher as Dow Hits New Record; Oil Slumps, Gold Holds Firm; Jobs Data, Xero, Orica & GrainCorp in Focus (13 Nov 2025)

Go toTop